Cobra Biologics and Novolytics Unveil Successful Development of Bacteriophages Against Bacterial Infection

Product News   Jun 12, 2013

 
Cobra Biologics and Novolytics Unveil Successful Development of Bacteriophages Against Bacterial Infection
 
 
FURTHER INFORMATION
 
 
 

Related Product News

Merck Expands End-to-End Biodevelopment Capability

Product News

Two new process development centers in the U.S. and China, in addition to its established center in France, will enhance Merck's end-to-end biodevelopment capabilities.

READ MORE

QC Insider™ Toolbox Feature Helps QC Professionals Manage LER

Product News

New FAQs tech tip in the QC Insider™ Toolbox helps QC Professionals manage the low endotoxin recovery phenomenon.

READ MORE

SSB Introduces New Released N-Glycan Assay

Product News

Sartorius Stedim Biotech introduces new physico-chemical assay for the in-depth profiling of IgG glycosylation.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE